Community pharmacy harm reduction services for drug misusers: National service delivery and professional attitude development over a decade in Scotland

Journal of Public Health

Volumn 29, Issue 4, 2007, Pages 350-357

  Matheson, Catriona ^a   Bond, Christine M ^a   Tinelli, Michela ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Community pharmacy; Dispensing; Drug misuse; Needle exchange; Treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOODBORNE BACTERIUM; CROSS-SECTIONAL STUDY; EVALUATION; FEMALE; HARM REDUCTION; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; NATIONAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PHARMACY; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; SUBSTANCE ABUSE; UNITED KINGDOM; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; BLOOD-BORNE PATHOGENS; BUPRENORPHINE; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HUMANS; MALE; METHADONE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; QUESTIONNAIRES; SCOTLAND; STATE MEDICINE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 36249028667     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdm064     Document Type: Article

References (16)

1. Berbatis CG, Sunderland VB, Bulsara M. The services provided by community pharmacists to prevent,minimise and manage drug misuse: an international perspective. In: Sheridan J, Strang J (eds). Drug Misuse and Community Pharmacy. London: Taylor and Francis, 2003, 73-83. ISBN: 0415 282 89 6.
2. Berbatis CG, Sunderland VB. The role of community pharmacy in methadone maintenance treatment. Final Report 2000. Barton (ACT Australia): Australian Association of Consultant Pharmacy. Appendices 1-3. ISBN: 1 86342 987 5.
3. Matheson C, Bond CM, Mollison J. Factors associated with community pharmadsts' involvement in services for drug misusers. Addiction 1999;94(9): 1349-59.
4. Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. Br Med J 1996;313:272-4.
5. Matheson Q Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction 2002;97:1405-11.
6. Hay G, Gannon M. Capture-recapture estimates of the local and national prevalence of problem drug use in Scotland. Int J Drug Policy 2006;17:203-10.
7. NHS. Change to the Lord Advocate's Guidance on needle and syringe distribution. Scottish Executive, Edinburgh, HDL 90, 2002.
8. Information and Statistics Division (ISD) Scotland. Drug Misuse Statistics Scotland 2004. Edinburgh: ISD Scotland, 2005.
9. Cameron J, Gilchrist G, Roberts K. Needle exchange Services: a profile of service users in community pharmacies and other setting. Int J Pharm Pract 2000;12:211-5.
10. Matheson C, Bond CM. Motivations and barriers to community pharmacy services for drug misusers. Int J Pharm Pract 1999;7(4):256-63.
11. Hall S, Matheson C. Barriers to community pharmacy needle exchange services. Int J Pharm Pract, 15(4).
12. Anderson C, Blenkinsopp A, Armstrong M. Pharmacists' perceptions regarding their contribution to improving the public's health: a systematic review of the United Kingdom and international literature 1990-2001. Int J Pharm Pract 2003;11(2):111 -20.
13. RPSGB. Medicines, Ethics and Practice 29. London: Royal Pharmaceutical Society of Great Britain, 2005
14. DoH Guidelines. Drug misuse and dependence - guidelines on clinical management. Department of Health, 1999, London: HMSO.
15. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2003 (Issue 2). Art. no. CD002207. doi: 10.1002/14651858. CD002207.pub2.
16. Cameron I, Matheson C, Bond CM. A Survey of Community Pharmacists training needs in the management of opioid dependent clients in Grampian, Scotland. Pharm J 2006;276:601-3.